The series on “Uncommon Mutations in Non-Small Cell Lung Cancer” is edited by Dr. Marco Russano, Department of Medical Oncology, University Campus Bio-Medico of Rome, Rome, Italy.
Marco Russano, MD
Department of Medical Oncology, University Campus Bio-Medico of Rome, Rome, Italy
Dr. Marco Russano received his MD degree and specialization in Medical Oncology with honors at University Campus Bio-Medico of Rome. His scientific activity and clinical practice has focused on thoracic malignancies, immunotherapy, biomarkers and targeted therapies. He has published several articles in international peer-reviewed journals and he is Sub-investigator of a series of phase II-III clinical trials mainly concerning lung cancer. He is currently carrying out the PhD project “exosomal miRNA as biomarkers in Non-Small-Cell Lung Cancer receiving Immune checkpoints Inhibitors”.
- Introduction to the series
- Significance of comprehensive molecular profiling in Non-Small Cell Lung Cancer
- Detection of uncommon mutations in Liquid Biopsy
- Uncommon EGFR mutations
- New driver mutations in Non-Small Cell Lung Cancer
- Role of immunotherapy for Non-Small Cell Lung Cancer with uncommon driver mutations
The series “Uncommon Mutations in Non-Small Cell Lung Cancer” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Dr. Marco Russano is serving as the unpaid Guest Editor for the series.